Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Regulation of Cardiac Fibroblast GLS1 Expression by Scleraxis.
Chattopadhyaya S, Nagalingam RS, Ledingham DA, Moffatt TL, Al-Hattab DS, Narhan P, Stecy MT, O'Hara KA, Czubryt MP. Chattopadhyaya S, et al. Among authors: nagalingam rs. Cells. 2022 Apr 27;11(9):1471. doi: 10.3390/cells11091471. Cells. 2022. PMID: 35563778 Free PMC article.
Regulation of cardiac fibroblast MMP2 gene expression by scleraxis.
Nagalingam RS, Safi HA, Al-Hattab DS, Bagchi RA, Landry NM, Dixon IMC, Wigle JT, Czubryt MP. Nagalingam RS, et al. J Mol Cell Cardiol. 2018 Jul;120:64-73. doi: 10.1016/j.yjmcc.2018.05.004. Epub 2018 May 8. J Mol Cell Cardiol. 2018. PMID: 29750994
What's in a name? On fibroblast phenotype and nomenclature 1.
Nagalingam RS, Al-Hattab DS, Czubryt MP. Nagalingam RS, et al. Can J Physiol Pharmacol. 2019 Jun;97(6):493-497. doi: 10.1139/cjpp-2018-0555. Epub 2018 Nov 23. Can J Physiol Pharmacol. 2019. PMID: 30468625 Review.
[No title available]
[No authors listed] [No authors listed] PMID: 35553142
Scleraxis and fibrosis in the pressure-overloaded heart.
Nagalingam RS, Chattopadhyaya S, Al-Hattab DS, Cheung DYC, Schwartz LY, Jana S, Aroutiounova N, Ledingham DA, Moffatt TL, Landry NM, Bagchi RA, Dixon IMC, Wigle JT, Oudit GY, Kassiri Z, Jassal DS, Czubryt MP. Nagalingam RS, et al. Eur Heart J. 2022 Dec 1;43(45):4739-4750. doi: 10.1093/eurheartj/ehac362. Eur Heart J. 2022. PMID: 36200607
Elimination of endogenous high molecular weight FGF2 prevents pressure-overload-induced systolic dysfunction, linked to increased FGFR1 activity and NR1D1 expression.
Koleini N, Nickel BE, Nagalingam RS, Landry NM, Fandrich RR, Cheung DYC, Dixon IM, Czubryt MP, Jassal DS, Cattini PA, Kardami E. Koleini N, et al. Among authors: nagalingam rs. Cell Tissue Res. 2021 Sep;385(3):753-768. doi: 10.1007/s00441-021-03465-0. Epub 2021 May 31. Cell Tissue Res. 2021. PMID: 34057573
18 results